Demand for Intravenous Immunoglobulin Will Expand At A CAGR Of 7.0% By 2026
The global immunoglobulins market shall expand strongly at a CAGR of 7.0% during the forecast period (2020-2026), largely attributed to the upsurge in prevalence of autoimmune diseases. According to the Immune Deficiency Foundation (IDF), approximately 83 per 100,000 people in North America suffered from primary immunodeficiency in 2017, covering 350 genetic diseases. As the global geriatric...
0 Comments 0 Shares 2K Views 0 Reviews
Sponsored